FOXO3, however, has been associated with tumour suppression, as indicated by studies showing that prevention of FOXO3 inactivation due to nuclear export reduces levels of ibrutinib resistance in DLBCL (131). This evidence concerns the gene FOXO3 and diffuse large B-cell lymphoma.